Search Results

Quizartinib 5 mg  | Purity Not Available

TargetMol

Quizartinib is an inhibitor of FLT3 (Kd: 1.6 nM) and demonstrates high selectivity for FLT3 when tested against a panel of 227 additional kinases.

More Information Supplier Page

Quizartinib 50 mg  | Purity Not Available

TargetMol

Quizartinib is an inhibitor of FLT3 (Kd: 1.6 nM) and demonstrates high selectivity for FLT3 when tested against a panel of 227 additional kinases.

More Information Supplier Page

Quizartinib 10 mg  | Purity Not Available

TargetMol

Quizartinib is an inhibitor of FLT3 (Kd: 1.6 nM) and demonstrates high selectivity for FLT3 when tested against a panel of 227 additional kinases.

More Information Supplier Page

Quizartinib 100 mg  | Purity Not Available

TargetMol

Quizartinib is an inhibitor of FLT3 (Kd: 1.6 nM) and demonstrates high selectivity for FLT3 when tested against a panel of 227 additional kinases.

More Information Supplier Page

T0070907 200 mg  | Purity Not Available

TargetMol

T0070907(IC50=1 nM) , an effective and specific PPARγ inhibitor, with the >800-fold selectivity over PPARα and PPARδ.

More Information Supplier Page

SKI II 200 mg  | 99.97%

TargetMol

SKI II is a highly selective and non-ATP-competitive S1P receptor inhibitor (IC50: 0.5 μM) while exhibiting no inhibitory action on other kinases including PKCα, PI3K, and ERK2.

More Information Supplier Page